The uptick in the Morepen Labs share came after the company announced that it has rolled out ‘Empamore.’ Empamore is used to ...

The Drug is produced at the USFDA approved facilities of Morepen, which is compliant with global quality standards for ...

Morepen Laboratories Limited announces the launch of Empamore, a game-changing treatment for Type 2 Diabetes Mellitus, Heart ...

Morepen Labs has executed a Business Transfer Agreement (BTA) with Morepen Medtech for the transfer of its medical devices ...

Haryana: Morepen Labs has announced that the Ministry of Corporate Affairs has approved the incorporation of 'QUICK MED ...

Pharmaceutical company Morepen Laboratories Ltd on Monday (March 17) said it has launched a new treatment for Type 2 diabetes, heart failure, and chronic kidney disease. The drug, Empamore, is said to ...

Morepen Laboratories surged 8.90% to Rs 46.61 after the company launched Empamore, an affordable treatment for type 2 diabetes, heart failure, and chronic kidney disease in India.

Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

On Wednesday, 3018 stocks advanced, 1033 declined and 115 remained unchanged, with an advance decline ratio of 2.92 on the ...

Equity markets surge on positive global cues, banking stocks lead gains, Sensex closes at 75,301.26, Nifty at 22,834.30.

The NSE Nifty 50 ended 1.45% higher at 22,834.30, while the BSE Sensex closed 1.53% up at 75,301.26 on Tuesday.

108300.0 in Delhi. Intraday stocks for today under ₹100: Experts recommend four stocks to buy or sell on Friday — Imagicaaworld Entertainment, Dhani Services, SJVN, and Morepen Laboratories ...